Clinical Trial Update: A Study of Extending Relugolix Dosing Intervals Through Addition of Itraconazole or Ritonavir in Prostate Cancer Patients [Phase 1]

View source ↗

Summary

A Phase 1 trial investigating extending relugolix dosing intervals by co-administering itraconazole or ritonavir in prostate cancer patients; the study status i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Adenocarcinoma
• Prostate Cancer

Drugs mentioned

• Itraconazole (Itraconazole)
• Relugolix (Relugolix)
• Ritonavir (Ritonavir)

Snippet

Sponsor: University of Chicago | Conditions: Prostate Cancer, Prostate Cancer Metastatic | Phase 1 | Status: TERMINATED